<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A high-resolution two-dimensional <z:chebi fb="0" ids="53656">polyacrylamide</z:chebi> gel electrophoresis (2D-PAGE) was used for total cellular <z:chebi fb="1" ids="15841">polypeptide</z:chebi> mapping of two established <z:hpo ids='HP_0002665'>lymphoma</z:hpo> cell lines; MANCA, a Burkitt's line representing a high grade <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (HGL) and WSU-NHL (nodular histiocytic <z:hpo ids='HP_0002665'>lymphoma</z:hpo>) representing an intermediate grade <z:hpo ids='HP_0002665'>lymphoma</z:hpo> (IGL) </plain></SENT>
<SENT sid="1" pm="."><plain>Gels were digitized and analysed with an image scanning computer using the Elsie 4 system </plain></SENT>
<SENT sid="2" pm="."><plain><z:chebi fb="1" ids="15841">Polypeptide</z:chebi> mapping revealed striking similarities in 1100 polypeptide spots in both types </plain></SENT>
<SENT sid="3" pm="."><plain>However, three <z:chebi fb="1" ids="15841">polypeptides</z:chebi> were unique to HGL (Molecular mass/isoelectric point (Mr/PI): 39/4.4, 35/5.6, 33/4.8), and one to IGL (95/4.7) </plain></SENT>
<SENT sid="4" pm="."><plain>In order to investigate the kinetics of expression of these <z:chebi fb="1" ids="15841">polypeptides</z:chebi>, the two cell lines were treated with two protein kinase C (PKC) activators, <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> promoting 12-O tetradecanoylphorbol 13-<z:chebi fb="49" ids="30089,47622">acetate</z:chebi> (<z:chebi fb="6" ids="15702,53394">TPA</z:chebi>) and bryostatin 1 </plain></SENT>
<SENT sid="5" pm="."><plain>2D-PAGE of the treated cells revealed that the HGL line loses its unique <z:chebi fb="1" ids="15841">polypeptides</z:chebi> and expresses a new one </plain></SENT>
<SENT sid="6" pm="."><plain>The new <z:chebi fb="1" ids="15841">polypeptide</z:chebi> has the same Mr and PI as that unique to the untreated IGL (95/4.7) </plain></SENT>
<SENT sid="7" pm="."><plain><z:chebi fb="6" ids="15702,53394">TPA</z:chebi> or bryostatin 1 treatment of the IGL line for 72 h induced no significant changes </plain></SENT>
<SENT sid="8" pm="."><plain>Our data show a unidirectional change from HGL to IGL, supporting the clinical notion that HGL is less differentiated than IGL </plain></SENT>
<SENT sid="9" pm="."><plain>It also shows the similarity in the mode of action of bryostatin 1 and <z:chebi fb="6" ids="15702,53394">TPA</z:chebi> in inducing these <z:chebi fb="1" ids="15841">polypeptide</z:chebi> changes </plain></SENT>
</text></document>